2026 Medicare Part D Redesign: Up to 15% Drug Cost Impact
The 2026 Medicare Part D redesign introduces significant changes, including a $2,000 out-of-pocket cap, potentially impacting beneficiary prescription drug costs by up to 15% through altered premium structures and coverage phases.